![Pat Costello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pat Costello
Direttore/Membro del Consiglio presso Alucent Biomedical Inc.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Myles D. Greenberg | M | 56 |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
James Corbett | M | 65 |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Daniel Pelak | M | 72 |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | 6 anni |
David Flicek | M | - |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Ryan Hansen | M | - |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Julie Lautt | F | - |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 6 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Pat Costello
- Contatti personali